Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and St Hilda's College are delighted to announce the creation of a new Chair of Clinical Therapeutics thanks to initial, generous, philanthropic support from Professor John Climax. The donation was confirmed at a signing ceremony on Friday 15th December 2017.

Left to Right: Sir Gordon Duff, Principal of St Hilda's College; Professor John Climax; Professor Andrew Carr, Head of NDORMS; Dr Sarah Norman, Senior Tutor, St Hilda's College © John Cairns

Through the establishment of this Chair, Oxford will be in a position to address a significant challenge facing universities today: how to translate novel therapies quickly and sustainably from laboratory to clinic.

Under their leadership, the University will establish a new Centre for Clinical Therapeutics, based within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), headed by Professor Andrew Carr. Through this centre, the Chair will work to develop close partnerships within Oxford, and more widely with the pharmaceutical, biotechnology and diagnostics industries, in order to drive new drug treatments through early phase clinical trials.

Read more (on Oxford Thinking website)